A prognostic insight on in vivo expression of interleukin-6 in uterine cervical cancer

International Journal of Gynecological Cancer

Volumn 13, Issue 3, 2003, Pages 331-339

  Srivani, R ^a   Nagarajan, B ^a  

^a CANCER INSTITUTE WIA   (India)

Author keywords

Cancer; Interleukin 6; Prognostic significance; T cells; Tumor associated macrophages; Uterine cervix

Indexed keywords

CYTOKINE; INTERLEUKIN 6; MONOCLONAL ANTIBODY;

ANTIBODY SPECIFICITY; ARTICLE; CANCER GROWTH; CANCER INVASION; CANCER RADIOTHERAPY; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; FEMALE; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAJOR CLINICAL STUDY; PRECANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; STROMA CELL; UTERINE CERVIX CANCER; ADULT; AGED; BIOSYNTHESIS; CARCINOMA; IMMUNOLOGY; MIDDLE AGED; MINIMAL RESIDUAL DISEASE; T LYMPHOCYTE; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX TUMOR;

ADULT; AGED; CARCINOMA; CERVICAL INTRAEPITHELIAL NEOPLASIA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-6; MACROPHAGES; MIDDLE AGED; NEOPLASM, RESIDUAL; PRECANCEROUS CONDITIONS; PROGNOSIS; T-LYMPHOCYTES; UTERINE CERVICAL NEOPLASMS;

EID: 0642376742     PISSN: 1048891X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1438.2003.13197.x     Document Type: Article

References (29)

1. Reibnegger G, Krainer M, Herold M, Ludwig H, Watcher H, Huber H. Predictive value of IL-6 and Neopterin in patients with multiple myeloma. Cancer Res 1991;51:6250-3.
2. Takenawa J, Kaneko Y, Yoshida O et al. Enhanced expression of IL-6 in primary human renal cell cancers. J Natl Cancer Inst 1991;83:1668-72.
3. Van Meir E, Awamura Y, Diserens AC, Hamou MF, Tribolet ND. Human glioblastoma cells release IL-6 in vivo and in vitro. Cancer Res 1991;50:6683-8.
4. Erroi A, Sironi M, Chiaffarino F, Chen ZG, Mengozzi M, Mantovani A. IL-1 and IL-6 release by tumor associated macrophages from human ovarian cancers. Int J Cancer 1989;44:795-801.
5. Moretti S, Pinzi C, Berti E, Herlyn M. Immunohistochemical evidence of cytokine networks during progression of human melanocytic lesions. Int J Cancer 1999;84:160-8.
6. Miki S, Iwano M, Kishimoto T et al. IL-6 functions as an autocrine growth factor in renal cell cancers. FEBS Lett 1989;250:607-10.
7. Hobisch A, Rogatsch H, Culig Z et al. Immunohistochemical localization of IL-6 and its receptor in benign, premalignant and malignant prostatic tissue. J Pathol 2000;191:239-44.
8. Takano H, Harigaya K, Sekiya S et al. IL-6 production in carcinoma of cervix. Arch Gynecol Obstet 1996;258:25-33.
9. Woodworth CD, Simpson S. Comparative lymphokine secretion by cultured normal human keratinocytes, papillomavirus-immortalized, and carcinoma cell lines. Am J Pathol 1993;142:1544-55.
10. Iglesias M, Plowman GD, Woodworth CD. IL-6 and sIL-6R regulate proliferation of normal, HPV immortalized and carcinoma-derived cells in vitro. Am. J Pathol 1995;146:944-52.
11. Ferdeghini M, Gadducci A, Bianchi R et al. Serum interleukin-6 levels in uterine malignancies. Preliminary data. Anticancer Res 1994;14:735-7.
12. Eustace D, Han X, Gooding R, Rowbottom A, Riches P, Heyderman E. IL-6 functions as an autocrine growth factor in cervical carcinoma in-vitro. Gynecol Oncol 1993;50:15-9.
13. Chopra V, Dinh TV, Hannigan EV. Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer. Cancer Invest 1998;16:152-9.
14. Pao CC, Lin CY, Yao DS, Tseng CJ. Differential expression of cytokine genes in cervical cancer tissues. Biochem Biophys Res Commun 1995;214:1146-51.
15. Castrilli G, Tatone D, Diodoro MG, Rosini S, Piantelli M, Musiani P. IL-1 and IL-6 promote in-vitro growth of both normal and neoplastic human cervical epithelial cells. Br J Cancer 1997;75:855-9.
16. Scambia G, Testa U, Mancuso S et al. IL-6 serum levels in patients with gynecologic tumors. Int J Cancer 1994;57:318-23.
17. Punnonen R, Teisala K, Kuoppala T, Bennett B, Punnonen J. Cytokine production profiles in the peritoneal fluids of patients with malignant or benign gynecologic tumors. Cancer 1998;83:788-96.
18. Kyo S, Kanaya T, Takakura M, Inoue M. A case of cervical cancer with aggressive tumor growth: possible autocrine growth stimulation by G-CSF and IL-6. Gynecol Oncol 2000;78:383-7.
19. Edwards RP, Kuykendall K, Crowley-Nowick P, Partridge EE, Shingleton HM, Mestecky J. T lymphocytes infiltrating advanced grades of cervical neoplasia. CD8-positive cells are recruited for invasion. Cancer 1995;76:1411-5.
20. Sheu BC, Hsu SM, Ho HN, Lin RH, Torng PL, Huang SC. Reversed CD4/CD8 ratios of tumor-infiltrating lymphocytes are correlated with the progression of human cervical carcinoma. Cancer 1999;86:1537-43.
21. Shimura S, Yang G, Ebara S, Wheeler T, Frolov A, Thompson TC. Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with tumor progression. Cancer Res, 2000;60:5857-61.
22. Tartour E, Gey A, Fridman WH et al. Analysis of IL-6 gene expression in cervical neoplasia using a Q-PCR assay: evidence for enhanced IL-6 gene expression in invasive cancer. Cancer Res 1994;54:6243-8.
23. Chouaib S, Paturel AC, Chouaib MM, Caignard A, Blay JY. The tumor-host immune conflict. Immunosuppression, resistance and destruction. Immunol Today 1997;18:493-7.
24. Brigati C, Noonal D, Albini A, Benelli R. Tumors and inflammatory infiltrates: Friends or foes? Clin Exp Med 2002;19:247-58.
25. Reynolds GM, Billingham LJ, Gray LJ et al. IL-6 expression by Hodgkin/Reed-Sternberg cells is associated with the presence of 'B' symptoms and failure to achieve complete remission in patients with advanced Hodgkin's disease. Br J Haematol 2002;118:195-201.
26. Frassanito MA, Cusmai A, Iodice G, Dammacco F. Autocrine IL-6 production and highly malignant multiple myeloma: relation withresistance to drug-induced apoptosis. Blood 2001;97:483-9.
27. Wei LH, Kuo ML, Hsieh CY et al. Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor. Gynecol Oncol 2001;82:49-56.
28. Smith PC, Keller ET. Anti-interleukin-6 monoclonal antibody induces regression of human prostate cancer xenografts in nude mice. Prostate 2001;48:47-53.
29. Conze D, Weiss L, Rincon M et al. Autocrine production of IL-6 causes multidrug resistance in breast cancer cells. Cancer Res 2001;61:8851-8.